Translation into English of this article on the study. Published by the Kavli Trust who supports Fluge and Mella's ME research team at Haukeland University Hospital and the University in Bergen. Promising results from trial of cancer drug in ME/CFS With support from Kavli Trust, the ME/CFS research group at Haukeland University Hospital led by doctors Øystein Fluge and Olav Mella, in collaboration with Alexander Fosså at the Oslo Radium Hospital, have completed a trial investigating treatment with the cytotoxic drug cyclophosphamide in ME/CFS. The trial was carried out from 2015 to 2017, and after long-term follow-up for up to 4 years the results are now published in Frontiers in Medicine. “The main conclusion is that treatment with cyclophosphamide was feasible for ME/CFS patients,” says lead author Ingrid Gurvin Rekeland.